4 Analysts Have This to Say About Celldex Therapeutics
Portfolio Pulse from Benzinga Insights
In the last 3 months, 4 analysts have offered 12-month price targets for Celldex Therapeutics (NASDAQ:CLDX), with an average price target of $68.25, up 24.09% from the previous average of $55.00. The company has received 3 bullish and 1 somewhat bullish ratings.
May 31, 2023 | 3:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Celldex Therapeutics has an average 12-month price target of $68.25, up 24.09% from the previous average, with 3 bullish and 1 somewhat bullish ratings from 4 analysts.
The increase in the average 12-month price target and the predominantly bullish ratings from analysts indicate a positive outlook for Celldex Therapeutics in the short term. This is likely to have a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100